Last reviewed · How we verify
NCT07124897
Virtual Reality-Supported Psychosocial Care for Women After Perinatal Loss
NA trial testing VR-Supported Psychosocial Nursing Care Based on Swanson's Theory of Caring in Perinatal Death in 100 participants. Not yet recruiting.
1 August 2026
Quick facts
| Lead sponsor | Duygu Dişli Çetinçay |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | supportive care |
| Enrollment | 100 |
| Start date | 20 August 2025 |
| Primary completion | 1 August 2026 |
| Estimated completion | 1 August 2026 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- VR-Supported Psychosocial Nursing Care Based on Swanson's Theory of Caring
- Psychosocial Nursing Care Based on Swanson's Theory of Caring
Conditions studied
- Perinatal Death — all drugs for Perinatal Death →
Sponsor
Duygu Dişli Çetinçay
Who can join
18 and older, female only, with Perinatal Death. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to evaluate the effect of virtual reality (VR)-supported psychosocial nursing care on the psychosocial health of women aged 18 and older who have experienced perinatal loss (≥20 weeks of gestation). The main questions it aims to answer are: Does VR-supported psychosocial care reduce depression, anxiety, stress, perinatal grief, and postpartum depression compared to psychosocial care without VR support? Researchers will compare two groups: VR-supported psychosocial care Psychosocial care without VR support Participants will complete baseline psychosocial assessments during hospital admission, receive psychosocial nursing care based on Swanson's Theory of Caring - with or without VR support - during hospitalization, take part in follow-up interviews on Day 7 and Day 30 after discharge, and continue the psychosocial care process at home, including practicing breathing exercises, keeping a daily journal, and receiving supportive information about coping after perinatal loss.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07124897
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Perinatal Death
Currently open trials in the same condition.
- NCT05187897 — CHV-NEO: Community-based Digital Communication to Support Neonatal Health · NA · recruiting
- NCT06005272 — Mothers Working to Prevent Early Stillbirth Study 20-28 · recruiting
- NCT06125860 — BEP Targeting Strategies in Ethiopia · NA · recruiting
- NCT06273007 — Improving Intrapartum Care for Saving Life at Birth in Ethiopia Through PartoMa Approach · NA · recruiting
- NCT04766866 — sFlt1/PlGF and Planned Delivery to Prevent Preeclampsia at Term. · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07124897 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Duygu Dişli Çetinçay
- Last refreshed: 15 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07124897.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing